封面
市場調查報告書
商品編碼
1166087

腦室引流的全球市場:現狀分析與預測(2022年~2028年)

External Ventricular Drain Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球腦室引流的市場規模,在預測期間內預計以約7%的年複合成長率成長。各種神經疾病的盛行率增加,全球交通事故數量的增加創傷性腦損傷增加,迅速的技術進步,研究開發活動的高漲,促進市場成長。

本報告提供全球腦室引流市場的相關調查,市場洞察,市場趨勢,競爭模式,企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 主要目的
  • 相關利益者
  • 限制

第2章 調查方法或假設

  • 腦室引流市場調查流程
  • 腦室引流市場調查手法
  • 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 COVID-19對腦室引流市場的影響

第6章 腦室引流市場收益(2022年~2028年)

第7章 市場洞察:各用途

  • 創傷性腦損傷
  • 顱內出血
  • 水腦症
  • 其他

第8章 市場洞察:各終端用戶

  • 醫院
  • 門診病人手術中心
  • 其他

第9章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區

第10章 腦室引流市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 腦室引流的市場機會

第12章 腦室引流的市場趨勢

第13章 需求面和供給方面的分析

  • 需求面分析
  • 供給面

第14章 價值鏈分析

第15章 競爭模式

  • 競爭情形
    • 波特的五力分析

第16章 企業概要

  • Medtronic Plc
  • Spiegelberg Gmbh & Co. Kg
  • Moller Medical Gmbh
  • Braun Melsungen Ag
  • Integra Life Sciences Corporation
  • Pfizer Inc.
  • Cadila Pharmaceuticals
  • Sophysa
  • Fuji Systems
  • Geistlich Pharma Inc.

第17章 免責聲明

簡介目錄
Product Code: UMHE211280

Global External Ventricular Drain Market is expected to grow at a significant rate of around 7% during the forecast period. The global external ventricular drain market is anticipated to witness an uptick owing to the growing prevalence of various neurological disorders and the rise in traumatic brain injuries due to an increase in the number of road accidents across the world. For instance, According to the World Health Organization, approximately 1.3 million people die every year as a result of road traffic crashes. Between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. Also, as per the United Nations data, in February 2021, nearly 1 in 6 of the world's population, suffer from neurological disorders, such as Alzheimer's and Parkinson's disease, strokes, etc. Furthermore, rapid technological advancement, rising research and development activities and an increasing need for minimally invasive or non-invasive neurosurgeries to reduce trauma and improve patient outcomes are also some of the factors contributing to the growth of the external ventricular drain market across the globe.

Medtronic Plc, Spiegelberg Gmbh & Co. Kg, Moller Medical Gmbh, Braun Melsungen Ag, Integra Life Sciences Corporation, Pfizer Inc., Cadila Pharmaceuticals, Sophysa, Fuji Systems, Geistlich Pharma Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new and innovative products.

Insights Presented in the Report

"Amongst application, traumatic brain injury category to witness higher CAGR during the forecast period"

Based on the application, the external ventricular drain market is segmented into traumatic brain injury, intracranial haemorrhage, hydrocephalus, and others. The traumatic brain injury segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to an increase in the number of road accidents leading to rise in the prevalence of traumatic brain injuries. However, the hydrocephalus segment is also expected to grow considerably during the forecast period as it affects a large number of people globally.

"Amongst end-user, the hospitals segment to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into hospitals, ambulatory surgical centers and others. The hospitals segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period. This can be due to an increased preference for patients to get treatment in hospitals owing to the presence of skilled healthcare professionals, availability of technologically advanced equipment, and a well-established infrastructure.

"North America to hold a significant share in the market"

North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, high incidences of traumatic brain injuries and a growing prevalence of neurovascular disorders in the region. For instance, as per the CDC, stroke is the fifth leading cause of death and over 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies are also contributing towards the growth of the market for the external ventricular drain in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global external ventricular drain market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the External Ventricular Drain Market
  • 2.2. Research Methodology of the External Ventricular Drain Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE EXTERNAL VENTRICULAR DRAIN MARKET

6 EXTERNAL VENTRICULAR DRAIN MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Traumatic Brain Injury
  • 7.2. Intracranial Haemorrhage
  • 7.3. Hydrocephalus
  • 7.4. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 EXTERNAL VENTRICULAR DRAIN MARKET OPPORTUNITIES

12 EXTERNAL VENTRICULAR DRAIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Medtronic Plc
  • 16.2. Spiegelberg Gmbh & Co. Kg
  • 16.3. Moller Medical Gmbh
  • 16.4. Braun Melsungen Ag
  • 16.5. Integra Life Sciences Corporation
  • 16.6. Pfizer Inc.
  • 16.7. Cadila Pharmaceuticals
  • 16.8. Sophysa
  • 16.9. Fuji Systems
  • 16.10. Geistlich Pharma Inc.

17 DISCLAIMER